These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5947968)

  • 21. The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis.
    Schölmerich J; Becher MS; Köttgen E; Rauch N; Häussinger D; Löhle E; Vuilleumier JP; Gerok W
    Hepatogastroenterology; 1983 Aug; 30(4):143-7. PubMed ID: 6685108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune inhibition of urea breakdown in patients with cirrhosis.
    Thomson A; Holmes AW
    Gastroenterology; 1967 Jan; 52(1):14-7. PubMed ID: 6018366
    [No Abstract]   [Full Text] [Related]  

  • 23. [Controlled protein administration diet and the prevention of hepatic encephalopathy].
    Strata A; Giuberti T; Magnati G; Regolisti M; Sacchini D; Fiaccadori F
    Minerva Dietol Gastroenterol; 1984; 30(3):245-50. PubMed ID: 6504373
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serum and urinary manganese in liver cirrhosis].
    Vai C; Andreuzzi B; Maida R; Gelosa F; Levati M
    Minerva Dietol Gastroenterol; 1983; 29(3):219-24. PubMed ID: 6633914
    [No Abstract]   [Full Text] [Related]  

  • 25. [Daily menus for diet therapy of liver cirrhosis].
    Matzkies F; Webs B; Totzke K
    Fortschr Med; 1982 Jun; 100(22):1041-6. PubMed ID: 6286436
    [No Abstract]   [Full Text] [Related]  

  • 26. [Symptoms of diabetes mellitus in liver cirrhosis].
    Tóth A; Tornóczky J; Parti G; Tóth G; Pierre B
    Orv Hetil; 1980 Apr; 121(14):819-25. PubMed ID: 7383658
    [No Abstract]   [Full Text] [Related]  

  • 27. Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion.
    McCullough AJ; Mullen KD; Kalhan SC
    Hepatology; 1998 Nov; 28(5):1357-64. PubMed ID: 9794922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The glucagon-dependent stimulation of cyclic AMP--a new diagnostic liver test?].
    Allgayer H; Hepp KD
    Z Gastroenterol; 1983 Jan; 21(1):1-4. PubMed ID: 6303006
    [No Abstract]   [Full Text] [Related]  

  • 29. Muscle GLUT4 in cirrhosis.
    Holland-Fischer P; Andersen PH; Lund S; Pedersen SB; Vinter-Jensen L; Nielsen MF; Kaal A; Dall R; Schmitz O; Vilstrup H
    J Hepatol; 2007 Aug; 47(2):212-9. PubMed ID: 17448565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced thyroidal uptake of inorganic iodine in liver cirrhosis.
    Sakurabayashi S; Sezai S; Yamamoto Y; Yoshino K; Hirano M; Iwase T; Oka H; Okano K
    J Med; 1996; 27(3-4):193-204. PubMed ID: 8982967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
    Krausz Y; Zylber-Katz E; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
    Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver].
    Loginov AS; Aruin LI; Shepeleva SD
    Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of protein intake using urinary urea nitrogen in patients with liver cirrhosis.
    Kida Y
    Scand J Gastroenterol; 2009; 44(5):615-8. PubMed ID: 19137458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients.
    Tangkijvanich P; Mahachai V; Wittayalertpanya S; Ariyawongsopon V; Isarasena S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):152-7. PubMed ID: 11023085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fat transport in cirrhosis.
    Swartz MG; Brewster AC; Sullivan JF
    Am J Med Sci; 1966 Dec; 252(6):701-8. PubMed ID: 6005915
    [No Abstract]   [Full Text] [Related]  

  • 38. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in carbohydrate metabolism in liver cirrhosis during glucose infusion tests].
    Rogos R; Meisel B; Erler K
    Z Gesamte Inn Med; 1982 Apr; 37(8):228-32. PubMed ID: 7051589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Angiotensin-converting enzyme inhibitors in liver function disorders?].
    Bönner G
    Dtsch Med Wochenschr; 1996 Feb; 121(8):254. PubMed ID: 8815027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.